Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	Oliena Studio Stroke and language recovery: 9000+ videos Español • Italiano • Sardu • English | PDF+

Vaccines

Free Subscription 22.04.2019 1 BMJ 1 Infect Immun 1 J Infect 1 J Infect Dis 5 J Virol 1 JAMA 4 Lancet 1 Lancet Child Adolesc Health 4 Lancet Glob Health 1 Lancet Oncol 4 Pediatr Infect Dis J 6 PLoS One 1 Science 15 Vaccine

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

BMJ

1. TANNE JH
   US county bars unvaccinated children from public spaces amid measles emergency.
   BMJ. 2019;364:l1481.
   PubMed     Text format    
   
   

   
   Infect Immun

2. MANI R, Gupta M, Malik A, Tandon R, et al
   Adjuvant Potential of Poly-alpha-L-glutamine from Cell Wall of Mycobacterium tuberculosis.
   Infect Immun. 2018 Aug 13. pii: IAI.00537-18. doi: 10.1128/IAI.00537.
   PubMed     Text format     Abstract available
   
   

   
   J Infect

3. GAIOTTINO J, Giovannoni G, Breuer J, Tang JW, et al
   Chronic-relapsing varicella zoster meningitis - successfully treated with varicella vaccine.
   J Infect. 2019 Apr 10. pii: S0163-4453(19)30121.
   PubMed     Text format    
   
   

   
   J Infect Dis

4. ATMAR RL, Baehner F, Cramer JP, Lloyd E, et al
   Antibody persistence to two Virus-Like Particle norovirus vaccine candidate formulations in healthy adults: one-year follow-up with memory probe vaccination.
   J Infect Dis. 2019 Apr 18. pii: 5475178. doi: 10.1093.
   PubMed     Text format     Abstract available
   
   

   
   J Virol

5. GOFFIN E, Javaux J, Destexhe E, Pretto CD, et al
   Oral vaccination with replication-competent adenovirus in mice reveals the dissemination of the viral vaccine beyond the gastrointestinal tract.
   J Virol. 2019 Apr 17. pii: JVI.00237-19. doi: 10.1128/JVI.00237.
   PubMed     Text format     Abstract available
   
   
6. TSAI YH, Huang SW, Hsieh WS, Cheng CK, et al
   Enterovirus A71 Containing Codon-Deoptimized VP1 and High-Fidelity Polymerase as Next Generation Vaccine Candidate.
   J Virol. 2019 Apr 17. pii: JVI.02308-18. doi: 10.1128/JVI.02308.
   PubMed     Text format     Abstract available
   
   
7. LUTEIJN RD, van Diemen F, Blomen VA, Boer IGJ, et al
   A genome-wide haploid genetic screen identifies heparan sulfate-associated genes and the macropinocytosis modulator TMED10 as factors supporting vaccinia virus infection.
   J Virol. 2019 Apr 17. pii: JVI.02160-18. doi: 10.1128/JVI.02160.
   PubMed     Text format     Abstract available
   
   
8. CALATAYUD O, Esperon F, Cleaveland S, Biek R, et al
   Carnivore parvovirus ecology in the Serengeti ecosystem: vaccine strains circulating and new host species identified.
   J Virol. 2019 Apr 17. pii: JVI.02220-18. doi: 10.1128/JVI.02220.
   PubMed     Text format     Abstract available
   
   
9. PANT A, Cao S, Yang Z
   Asparagine is a critical limiting metabolite for vaccinia virus protein synthesis during glutamine deprivation.
   J Virol. 2019 Apr 17. pii: JVI.01834-18. doi: 10.1128/JVI.01834.
   PubMed     Text format     Abstract available
   
   

   
   JAMA

10. GOSTIN LO, Ratzan SC, Bloom BR
    Safe Vaccinations for a Healthy Nation: Increasing US Vaccine Coverage Through Law, Science, and Communication.
    JAMA. 2019 Apr 19. pii: 2731738. doi: 10.1001/jama.2019.4270.
    PubMed     Text format    
    
    

    
    Lancet

11. GAUDINSKI MR, Coates EE, Novik L, Widge A, et al
    Safety, tolerability, pharmacokinetics, and immunogenicity of the therapeutic monoclonal antibody mAb114 targeting Ebola virus glycoprotein (VRC 608): an open-label phase 1 study.
    Lancet. 2019;393:889-898.
    PubMed     Text format     Abstract available
    
    
12. MALVY D, McElroy AK, de Clerck H, Gunther S, et al
    Ebola virus disease.
    Lancet. 2019;393:936-948.
    PubMed     Text format     Abstract available
    
    
13. KLUGMAN KP, Rodgers GL
    Population versus individual protection by pneumococcal conjugate vaccination.
    Lancet. 2019 Apr 15. pii: S0140-6736(19)30039.
    PubMed     Text format    
    
    
14. HAMMITT LL, Etyang AO, Morpeth SC, Ojal J, et al
    Effect of ten-valent pneumococcal conjugate vaccine on invasive pneumococcal disease and nasopharyngeal carriage in Kenya: a longitudinal surveillance study.
    Lancet. 2019 Apr 15. pii: S0140-6736(18)33005.
    PubMed     Text format     Abstract available
    
    

    
    Lancet Child Adolesc Health

15. THE LANCET CHILD ADOLESCENT HE
    Vaccine hesitancy: a generation at risk.
    Lancet Child Adolesc Health. 2019;3:281.
    PubMed     Text format    
    
    

    
    Lancet Glob Health

16. CHIDO-AMAJUOYI OG, Domgue JF, Obi-Jeff C, Schmeler K, et al
    Gender-neutral HPV vaccination in Africa - Authors' reply.
    Lancet Glob Health. 2019;7:e564.
    PubMed     Text format    
    
    
17. ZHUANG RY, Goyal H, Xu HG
    Gender-neutral HPV vaccination in Africa.
    Lancet Glob Health. 2019;7:e563.
    PubMed     Text format    
    
    
18. SIMONSEN L, van Wijhe M, Taylor R
    Are expensive vaccines the best investment in low-income and middle-income countries?
    Lancet Glob Health. 2019;7:e548-e549.
    PubMed     Text format    
    
    
19. OJAL J, Griffiths U, Hammitt LL, Adetifa I, et al
    Sustaining pneumococcal vaccination after transitioning from Gavi support: a modelling and cost-effectiveness study in Kenya.
    Lancet Glob Health. 2019;7:e644-e654.
    PubMed     Text format     Abstract available
    
    

    
    Lancet Oncol

20. BURKI TK
    Therapeutic HPV vaccine for cervical intraepithelial neoplasia.
    Lancet Oncol. 2019 Apr 12. pii: S1470-2045(19)30224.
    PubMed     Text format    
    
    

    
    Pediatr Infect Dis J

21. GIDDING HF, Sheridan S, Fathima P, Moore HC, et al
    Impact of Childhood Pneumococcal Conjugate Vaccine on Nonnotified Clinically Suspected Invasive Pneumococcal Disease in Australia.
    Pediatr Infect Dis J. 2019 Apr 10. doi: 10.1097/INF.0000000000002314.
    PubMed     Text format     Abstract available
    
    
22. MAKGATHO E, Patel F, Solomon F, Groome MJ, et al
    The Burden of Acute Diarrheal Disease in Young Hospitalized Urban South African Children Five Years After Rotavirus Vaccine Introduction: A Retrospective Descriptive Study.
    Pediatr Infect Dis J. 2019 Apr 10. doi: 10.1097/INF.0000000000002304.
    PubMed     Text format     Abstract available
    
    
23. CORONEL D, Garcia-Rivera EJ, Rivera M, Arredondo-Garcia JL, et al
    Dengue Vaccine Booster in Healthy Adolescents and Adults in Latin America: Evaluation 4-5 Years After a Primary 3-Dose Schedule.
    Pediatr Infect Dis J. 2019;38:e90-e95.
    PubMed     Text format     Abstract available
    
    
24. HEMMING-HARLO M, Lahdeaho ML, Maki M, Vesikari T, et al
    Rotavirus Vaccination Does Not Increase Type 1 Diabetes and May Decrease Celiac Disease in Children and Adolescents.
    Pediatr Infect Dis J. 2019;38:539-541.
    PubMed     Text format     Abstract available
    
    

    
    PLoS One

25. WILLIAMS LBA, Fry LM, Herndon DR, Franceschi V, et al
    A recombinant bovine herpesvirus-4 vectored vaccine delivered via intranasal nebulization elicits viral neutralizing antibody titers in cattle.
    PLoS One. 2019;14:e0215605.
    PubMed     Text format     Abstract available
    
    
26. MOONSAMY S, Suchard M, Madhi SA
    Effect of HIV-exposure and timing of anti-retroviral treatment on immunogenicity of trivalent live-attenuated polio vaccine in infants.
    PLoS One. 2019;14:e0215079.
    PubMed     Text format     Abstract available
    
    
27. WILLIAMS GA, Koenen ME, Havenaar R, Wheeler P, et al
    Survival of Mycobacterium bovis BCG oral vaccine during transit through a dynamic in vitro model simulating the upper gastrointestinal tract of badgers.
    PLoS One. 2019;14:e0214859.
    PubMed     Text format     Abstract available
    
    
28. ROWELL J, Lo CY, Price GE, Misplon JA, et al
    The effect of respiratory viruses on immunogenicity and protection induced by a candidate universal influenza vaccine in mice.
    PLoS One. 2019;14:e0215321.
    PubMed     Text format     Abstract available
    
    
29. ALKIE TN, Yitbarek A, Taha-Abdelaziz K, Astill J, et al
    Characterization of immunogenicity of avian influenza antigens encapsulated in PLGA nanoparticles following mucosal and subcutaneous delivery in chickens.
    PLoS One. 2018;13:e0206324.
    PubMed     Text format     Abstract available
    
    
30. DEBELLUT F, Hendrix N, Ortiz JR, Lambach P, et al
    Forecasting demand for maternal influenza immunization in low- and lower-middle-income countries.
    PLoS One. 2018;13:e0199470.
    PubMed     Text format     Abstract available
    
    

    
    Science

31. COHEN J
    Ebola outbreak continues despite powerful vaccine.
    Science. 2019;364:223.
    PubMed     Text format    
    
    

    
    Vaccine

32. VAUGHN AR, Johnson ML
    Communicating and enhancing teachers' attitudes and understanding of influenza using refutational text.
    Vaccine. 2018 Oct 17. pii: S0264-410X(18)31406.
    PubMed     Text format     Abstract available
    
    
33. MIHIGO R, Okeibunor J, Cernuschi T, Petu A, et al
    Improving access to affordable vaccines for middle-income countries in the african region.
    Vaccine. 2019 Apr 9. pii: S0264-410X(19)30426.
    PubMed     Text format     Abstract available
    
    
34. RIES C, Beer M, Hoffmann B
    BTV antibody longevity in cattle five to eight years post BTV-8 vaccination.
    Vaccine. 2019 Apr 9. pii: S0264-410X(19)30440.
    PubMed     Text format     Abstract available
    
    
35. GORMAN DR, Bielecki K, Willocks LJ, Pollock KG, et al
    A qualitative study of vaccination behaviour amongst female Polish migrants in Edinburgh, Scotland.
    Vaccine. 2019 Apr 9. pii: S0264-410X(19)30422.
    PubMed     Text format     Abstract available
    
    
36. NEUKAM K, Gutierrez-Valencia A, Llaves-Flores S, Espinosa N, et al
    Response to a reinforced hepatitis B vaccination scheme in HIV-infected patients under real-life conditions.
    Vaccine. 2019 Apr 10. pii: S0264-410X(19)30351.
    PubMed     Text format     Abstract available
    
    
37. ATTWELL K, Drislane S, Leask J
    Mandatory vaccination and no fault vaccine injury compensation schemes: An identification of country-level policies.
    Vaccine. 2019 Apr 15. pii: S0264-410X(19)30414.
    PubMed     Text format     Abstract available
    
    
38. O'MAHONY JF, Paulden M
    Appraising the cost-effectiveness of vaccines in the UK: Insights from the Department of Health Consultation on the revision of methods guidelines.
    Vaccine. 2019 Apr 15. pii: S0264-410X(19)30421.
    PubMed     Text format     Abstract available
    
    
39. ALBERTS CJ, Boyd A, Bruisten SM, Heijman T, et al
    Hepatitis A incidence, seroprevalence, and vaccination decision among MSM in Amsterdam, the Netherlands.
    Vaccine. 2019 Apr 13. pii: S0264-410X(19)30382.
    PubMed     Text format     Abstract available
    
    
40. VAN BUYNDER PG, Van Buynder JL, Menton L, Thompson G, et al
    Antigen specific vaccine hesitancy in pregnancy.
    Vaccine. 2019 Apr 13. pii: S0264-410X(19)30472.
    PubMed     Text format     Abstract available
    
    
41. ANTONUCCI R, Frassetto R, Vacca N, Mura D, et al
    Poor vaccine-related immunity against HBV in children with autoimmune diseases: Early or late sign of immunological disorder?
    Vaccine. 2019;37:2527-2528.
    PubMed     Text format    
    
    
42. PACHECO FC, Franca GVA, Elidio GA, Domingues CMAS, et al
    Trends and spatial distribution of MMR vaccine coverage in Brazil during 2007-2017.
    Vaccine. 2019 Apr 12. pii: S0264-410X(19)30470.
    PubMed     Text format     Abstract available
    
    
43. LEROUX-ROELS G, De Boever F, Maes C, Nguyen TL, et al
    Safety and immunogenicity of a respiratory syncytial virus fusion glycoprotein F subunit vaccine in healthy adults: Results of a phase 1, randomized, observer-blind, controlled, dosage-escalation study.
    Vaccine. 2019 Apr 12. pii: S0264-410X(19)30449.
    PubMed     Text format     Abstract available
    
    
44. MCGIRR A, Widenmaier R, Curran D, Espie E, et al
    The comparative efficacy and safety of herpes zoster vaccines: A network meta-analysis.
    Vaccine. 2019 Apr 11. pii: S0264-410X(19)30455.
    PubMed     Text format     Abstract available
    
    
45. AZZARI C, Serranti D, Nieddu F, Moriondo M, et al
    Significant impact of pneumococcal conjugate vaccination on pediatric parapneumonic effusion: Italy 2006-2018.
    Vaccine. 2019 Apr 10. pii: S0264-410X(19)30450.
    PubMed     Text format     Abstract available
    
    
46. SHAPIRO SZ
    Lessons for general vaccinology research from attempts to develop an HIV vaccine.
    Vaccine. 2019 Apr 9. pii: S0264-410X(19)30442.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Vaccines is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: